Literature DB >> 15927813

A novel method to control the balance of skin microflora. Part 1. Attack on biofilm of Staphylococcus aureus without antibiotics.

Masako Katsuyama1, Katsuyama Masako, Hideyuki Ichikawa, Ichikawa Hideyuki, Shigeyuki Ogawa, Ogawa Shigeyuki, Zenro Ikezawa, Ikezawa Zenro.   

Abstract

BACKGROUND: Staphylococcus aureus (SA) is usually present in atopic dry skin, and not only in regions seriously affected by atopic dermatitis. SA discharges various toxins and enzymes that injure the skin, and forms a biofilm from fibrin fiber and glycocalyx; the biofilm is important for adhesion of SA to the skin and for resistance to anti-microbial agents. Even highly effective moisturizers do not work perfectly on atopic dry skin. Staphylococcus epidermidis (SE) is a major constituent of skin microflora on healthy human skin, and provides protection against the growth of pathogenic bacteria.
OBJECTIVES: Since treatment with anti-microbials may lead to re-growth of SA, which grows faster than other Staphylococci and often shows antibiotic resistance, we searched for novel approaches to control the skin-microfloral balance without using conventional anti-microbials.
METHOD: Biofilm formation by SA in vitro was observed in detail using scanning electron microscopy. Approximately 500 substances were screened for a selective effect on SA growth and SA biofilm.
RESULTS: We found that xylitol inhibited the formation of glycocalyx, and farnesol dissolved fibrin fibers. Farnesol suppressed the growth of only SA, and did not affect that of SE. Xylitol and farnesol synergistically inhibited biofilm formation by SA.
CONCLUSION: Xylitol and farnesol have potential for controlling the skin-microfloral balance because of their selective effects and inhibition of biofilm formation. They might provide a useful and safe method to care for skin colonized by SA, without using antibiotics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15927813     DOI: 10.1016/j.jdermsci.2005.01.006

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  22 in total

1.  Effects of xylitol on xylitol-sensitive versus xylitol-resistant Streptococcus mutans strains in a three-species in vitro biofilm.

Authors:  Aino M Marttinen; Patricia Ruas-Madiedo; Claudio Hidalgo-Cantabrana; Markku A Saari; Riikka A Ihalin; Eva M Söderling
Journal:  Curr Microbiol       Date:  2012-05-30       Impact factor: 2.188

Review 2.  [Pre- and probiotic cosmetics].

Authors:  R Simmering; R Breves
Journal:  Hautarzt       Date:  2009-10       Impact factor: 0.751

3.  The effects of farnesol on Staphylococcus aureus biofilms and osteoblasts. An in vitro study.

Authors:  Aasis Unnanuntana; Lindsay Bonsignore; Mark E Shirtliff; Edward M Greenfield
Journal:  J Bone Joint Surg Am       Date:  2009-11       Impact factor: 5.284

4.  Tissue Plasminogen Activator Coating on Implant Surfaces Reduces Staphylococcus aureus Biofilm Formation.

Authors:  Jakub Kwiecinski; Manli Na; Anders Jarneborn; Gunnar Jacobsson; Marijke Peetermans; Peter Verhamme; Tao Jin
Journal:  Appl Environ Microbiol       Date:  2015-10-30       Impact factor: 4.792

5.  Biofilm formation by Staphylococcus aureus isolates from skin and soft tissue infections.

Authors:  Jakub Kwiecinski; Gunnar Kahlmeter; Tao Jin
Journal:  Curr Microbiol       Date:  2015-01-14       Impact factor: 2.188

6.  Diabetic foot infection: A critical complication.

Authors:  Jennifer J Hurlow; Gavin J Humphreys; Frank L Bowling; Andrew J McBain
Journal:  Int Wound J       Date:  2018-05-28       Impact factor: 3.315

7.  Combined treatment of Pseudomonas aeruginosa biofilm with lactoferrin and xylitol inhibits the ability of bacteria to respond to damage resulting from lactoferrin iron chelation.

Authors:  Mary Cloud B Ammons; Loren S Ward; Scot Dowd; Garth A James
Journal:  Int J Antimicrob Agents       Date:  2011-03-05       Impact factor: 5.283

8.  Interventions to reduce Staphylococcus aureus in the management of eczema.

Authors:  Susannah Mc George; Sanja Karanovic; David A Harrison; Anjna Rani; Andrew J Birnie; Fiona J Bath-Hextall; Jane C Ravenscroft; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2019-10-29

9.  The role of staphylothrombin-mediated fibrin deposition in catheter-related Staphylococcus aureus infections.

Authors:  Thomas Vanassche; Marijke Peetermans; Lucas N L Van Aelst; Willy E Peetermans; Jan Verhaegen; Dominique M Missiakas; Olaf Schneewind; Marc F Hoylaerts; Peter Verhamme
Journal:  J Infect Dis       Date:  2013-03-26       Impact factor: 5.226

10.  A Role of Staphyococcus aureus, Interleukin-18, Nerve Growth Factor and Semaphorin 3A, an Axon Guidance Molecule, in Pathogenesis and Treatment of Atopic Dermatitis.

Authors:  Zenro Ikezawa; Junko Komori; Yuko Ikezawa; Yusuke Inoue; Mio Kirino; Masako Katsuyama; Michiko Aihara
Journal:  Allergy Asthma Immunol Res       Date:  2010-05-12       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.